Drug intelligence / Profile preview

g-csf-primed peripheral blood stem cells

Development stage
Unknown
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

G-CSF-primed peripheral blood stem cells (G-PBSCs) are a type of allogeneic or autologous transplant graft used in hematopoietic stem cell transplantation (HSCT). These cells are obtained by administering granulocyte colony-stimulating factor (G-CSF) to a donor, which mobilizes hematopoietic stem and progenitor cells (HSPCs) from the bone marrow into the peripheral blood, where they can be collected via apheresis. G-PBSCs are the most common source of stem cells for adult HSCT due to the ease of collection and rapid hematopoietic recovery (engraftment) compared to bone marrow-derived cells. They are used to treat a wide range of conditions, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndromes, and severe aplastic anemia. In the context of haploidentical transplantation, G-CSF priming of the donor is a critical component of protocols like the Beijing Protocol to ensure adequate cell yields and modulate the graft's T-cell composition.

Other names
G-CSF-mobilized peripheral blood stem cellsG-CSF-primed PBSCsG-CSF-mobilized PBSCsgranulocyte colony-stimulating factor-primed peripheral blood stem cells

Beyond the preview

Go deeper on g-csf-primed peripheral blood stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on g-csf-primed peripheral blood stem cells.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call